• CORPORATE EVENTS: Medarex, Inc. (“MEDX”)

      • To
      • Clearing Member Firms
      • From
      • CME Clearing
      • #
      • 09-383
      • Notice Date
      • 02 September 2009
      • Effective Date
      • 03 September 2009

    • On August 31, 2009, Puma Acquisition Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company completed its subsequent tender offer for Medarex, Inc. (“MEDX”)

      ComCommon Shares. The merger was subsequently consummated on September 1, 2009. As a result, each existing MEDX Common Share will be converted into the right to receive

      $16.00 net cash per share.

       

      This corporate event will be coordinated with the Options Clearing Corporation.

      For the full text of this advisory...

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.